Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma : A Phase II study
โ Scribed by Javier Rodriguez; Javier Cortes; Emiliano Calvo; Ignacio Azinovic; Oscar Fernandez-Hildago; Rafael Martinez-Monge; Carlos Garzon; Jokin de Irala; Maite Martinez-Aguillo; Teresa Ramon y Cajal; Antonio Brugarolas
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 90 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The authors conducted a Phase II study to evaluate the activity of the combination of gemcitabine and vinorelbine in patients with advanced nonsmall cell lung carcinoma (NSCLC). ## METHODS. Patients were eligible if they had Stage IIIB (malignant pleural effusion) or Stage IV NSCLC, no prior chemo
## Background: Combination chemotherapy comprised of oral uft (a combination of tegafur and uracil) and cisplatin was shown to be an effective regimen for the treatment of advanced nonsmall cell lung carcinoma and to be associated with a low incidence rate of toxicity in a previous, single institut